Clinical Trials Directory

Trials / Conditions / Generalized Myasthenia Gravis (gMG)

Generalized Myasthenia Gravis (gMG)

9 registered clinical trials studyying Generalized Myasthenia Gravis (gMG) — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingZilucoplan for Severe gMG Exacerbations
NCT07215949
Miriam FreimerPhase 3
RecruitingEpidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russi
NCT07247279
AstraZeneca—
RecruitingADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens i
NCT07294170
argenx—
RecruitingADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Particip
NCT07284420
argenxPhase 2
RecruitingGC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)
NCT07058298
Daishi TianEARLY_Phase 1
Not Yet RecruitingAn Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia
NCT06759948
Chongbo ZhaoPhase 1
CompletedEfficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With
NCT06764160
Alexion Pharmaceuticals, Inc.Phase 3
Active Not RecruitingRESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia
NCT06359041
Cabaletta BioPhase 1 / Phase 2
RecruitingStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
NCT06312644
Alexion Pharmaceuticals, Inc.—